Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (351-360 of 418) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Neutral macrocyclic factor VIIa inhibitorsNicholas R Wurtz, Brandon L Parkhurst, Indawati DeLucca, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimizationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.
Journal of Medicinal Chemistry|January 14, 2017
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide LinkerJames R Corte, Tianan Fang, Honey Osuna, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitorMimi L Quan, Patrick Y S Lam, Qi Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2020
Orally bioavailable amine-linked macrocyclic inhibitors of factor XIaTianan Fang, James R Corte, Paul J Gilligan, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2020
Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJMichael C Myers, Donna M Bilder, Cullen L Cavallaro, et al.
Journal of Medicinal Chemistry|March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical CandidateJames A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Pageof 42

Showing results (351-360 of 418) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Neutral macrocyclic factor VIIa inhibitorsNicholas R Wurtz, Brandon L Parkhurst, Indawati DeLucca, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimizationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.
Journal of Medicinal Chemistry|January 14, 2017
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide LinkerJames R Corte, Tianan Fang, Honey Osuna, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitorMimi L Quan, Patrick Y S Lam, Qi Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2020
Orally bioavailable amine-linked macrocyclic inhibitors of factor XIaTianan Fang, James R Corte, Paul J Gilligan, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2020
Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJMichael C Myers, Donna M Bilder, Cullen L Cavallaro, et al.
Journal of Medicinal Chemistry|March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical CandidateJames A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Pageof 42